(Q34140740)

31 July 2017

1 reference

title

Low-density lipoprotein apheresis in the treatment of atherosclerosis and other potential uses (English)

1 reference

31 July 2017

1 reference

1 reference

Moriarty PM

1

1 reference

31 July 2017

Gibson CA

series ordinal

2

1 reference

31 July 2017

publication date

1 March 2001

1 reference

Current Atherosclerosis Reports

31 July 2017

published in

1 reference

31 July 2017

volume

3

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

156-162

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-001-0052-5

31 July 2017

exact match

0 references

cites work

Hemodynamic changes in the peripheral circulation after repeat low density lipoprotein apheresis in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0052-5

LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0052-5

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0052-5

Plasma viscosity as a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0052-5

Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0052-5

C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0052-5

[Hypercholesteremia and hyperfibrinogenemia in sudden deafness]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0052-5

Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0052-5

Improvements in hostility and depression in relation to dietary change and cholesterol lowering. The Family Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0052-5

Improved neurological recovery of cerebral infarctions after plasmapheretic reduction of lipids and fibrinogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0052-5

Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis

21 January 2018

1 reference

12 December 2020

Did grandma give you heart disease? The new battle against coronary artery disease

1 reference

12 December 2020

Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group

1 reference

12 December 2020

Statins and the risk of dementia

1 reference

12 December 2020

Idiopathic sudden sensorineural hearing loss

1 reference

12 December 2020

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

12 December 2020

Low-density lipoprotein apheresis therapy during pregnancy

1 reference

12 December 2020

H.E.L.P. apheresis therapy in the treatment of severe hypercholesterolemia: 10 years of clinical experience

1 reference

12 December 2020

Improvement of coronary vasodilatation capacity through single LDL apheresis

1 reference

12 December 2020

The Microspheres based Detoxification System (MDS). A new extracorporeal blood purification technology based on recirculated microspherical adsorbent particles

1 reference

12 December 2020

The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concen

1 reference

12 December 2020

Lipids, protein intake, and diabetic nephropathy.

1 reference

12 December 2020

Low-density lipoprotein apheresis retards the progression of hyperlipidemic overt diabetic nephropathy

1 reference

12 December 2020

Hypercholesterolemia--a determinant of renal function loss and deaths in IDDM patients with nephropathy

1 reference

12 December 2020

Cholesterol: a renal risk factor in diabetic nephropathy?

1 reference

12 December 2020

Heparin-induced extracorporal low-density-lipoprotein precipitation (H.E.L.P.) to improve the recovery of hearing in patients with sudden idiopathic hearing loss.

1 reference

12 December 2020

Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans

1 reference

12 December 2020

Enhanced inflammatory response in patients with preinfarction unstable angina

1 reference

12 December 2020

Increased subendothelial infiltration of the coronary arteries with monocytes/macrophages in patients with unstable angina. Histological data on 14 autopsied patients

1 reference

12 December 2020

Long-term effects of LDL apheresis on carotid arterial atherosclerosis in familial hypercholesterolaemic patients.

1 reference

12 December 2020

Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

1 reference

12 December 2020

Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemia

1 reference

12 December 2020

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

12 December 2020

C-reactive protein and other markers of inflammation among patients undergoing HELP LDL apheresis

1 reference

12 December 2020

Independent prognostic value of elevated C-reactive protein in unstable angina

1 reference

12 December 2020

Hypocholesterolemia and affective disorders

1 reference

12 December 2020

Increased cerebral CO(2) reactivity after heparin-mediated extracorporal LDL precipitation (HELP) in patients with coronary heart disease and hyperlipidemia

1 reference

12 December 2020

Incorporation of low-density lipoprotein apheresis into the treatment program of patients with severe hypercholesterolemia

1 reference

12 December 2020

Regression of transplant coronary artery disease during chronic low-density lipoprotein-apheresis.

1 reference

12 December 2020

Plasma fibrinogen--a major coronary risk factor

1 reference

12 December 2020

Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS)

1 reference

12 December 2020

Post-transplant hyperlipidaemia: low-dose lovastatin lowers atherogenic lipids without plasma accumulation of lovastatin

1 reference

12 December 2020

Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances

1 reference

12 December 2020

24th Bethesda conference: Cardiac transplantation. Task Force 5: Complications.

1 reference

12 December 2020

Peripheral vasoactivity in familial hypercholesterolemic subjects treated with heparin-induced extracorporeal LDL precipitation (HELP).

1 reference

12 December 2020

Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber

1 reference

12 December 2020

Extracorporeal adsorbent-based strategies in sepsis

1 reference

12 December 2020

Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk

1 reference

12 December 2020

Plasmapheresis in the therapy of septic disease

1 reference

12 December 2020

10.1007/S11883-001-0052-5

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1032590502

0 references

1 reference